Quick Takeaways
- Anil Kapur has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $116,495.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Anil Kapur
- Location
- New York, NY
- Summary
- The estimated net worth of Anil Kapur is at least $116,495 dollars as of 27 May 2025. Anil Kapur is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116.5K.
- Signature
- /s/ Daniel Calkins, Attorney in Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Anil Kapur and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Verastem, Inc. ($116,495).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Anil Kapur
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VSTM | Verastem, Inc. | Director | $116,495 | 22 May 2025 | ||
| GERN | GERON CORP | EVP, Corp Strategy & CCO | $0 | 10 Jun 2024 | ||
| NRIX | Nurix Therapeutics, Inc. | Director | 19 May 2025 |
Insider Transactions Reported by Anil Kapur:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.